Health Canada accepts Sucampo’s new drug submission for constipation drug Amitiza
Amitiza is a prostone and a locally acting chloride channel activator indicated in the US to treat CIC and OIC in adults. The company said that the effectiveness
Amitiza is a prostone and a locally acting chloride channel activator indicated in the US to treat CIC and OIC in adults. The company said that the effectiveness
Bekinda (RHB-102) is a proprietary once-daily oral pill formulation of the antiemetic drug ondansetron. The UK MHRA has started the formal review process for the MAA on 30
The agreement granted Takeda exclusive rights to market ferumoxytol in Canada, EU and Switzerland, as well as certain other geographic territories As part of the termination deal, AMAG
The drug is indicated for use in adults to manage pain, by taking it alone or in combination with opioid analgesics. Hospira senior vice-president and chief scientific officer
In 2009, both the firms established the original agreement to develop and commercialise Complera, marketed as Eviplera, which combines tenofovir disoproxil fumarate, emtricitabine and rilpivirine in a once-daily
The company has filed an application for use as a high-dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation in patients with multiple myeloma. In addition, the
FDA has approved the new drug application (NDA) for Namzaric to treat moderate to severe dementia of the Alzheimer’s type in patients stabilised on memantine hydrochloride and donepezil
After securing clinical trial application (CTA) regulatory approval, the company plans to conduct a Phase I trial to assess the safety, tolerability and dose escalation of Anatabine Citrate
SB742457 has shown promise for patients with mild-to-moderate Alzheimer’s disease in 13 clinical studies conducted to date by GSK using more than 1,250 healthy subjects and Alzheimer’s disease
The company will assess the efficacy and tolerability of tipifarnib as a potential new therapy for patients infected with Hepatitis Delta Virus (HDV). The Eiger BioPharmaceuticals subsidiary is